US Patent 11905326 Multispecific heavy chain antibodies binding to CD22 and CD3
Patent 11905326 was granted and assigned to TeneoBio on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+29 properties)
Article (+323 characters)
US Patent 11905326 Multispecific heavy chain antibodies binding to CD22 and CD3
Article
Patent abstract
Multispecific, human heavy chain antibodies (e.g., UniAbs™) binding to CD22 and CD3 are disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat disorders that are characterized by the expression of CD22.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Harshad Ugamraj0
Kirthana Prabhakar0
Nathan Trinklein0
Suhasini Iyer0
Udaya Rangaswamy0
Date of Patent
February 20, 2024
0Patent Application Number
169005860
Date Filed
June 12, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11905326 Multispecific heavy chain antibodies binding to CD22 and CD3
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.